Immuto Scientific
PrivateLast Round
Seed 2
Sep 18, 2025
Total Funding Raised
$13.84M
Company Overview
Immuto Scientific operates in Healthcare & Life Sciences and is based in Madison, Wisconsin. Its latest recorded funding round was a Seed 2 round in September 2025.
Immuto Scientific is a biotechnology company that provides analytical research services for drug discovery using its proprietary platform for protein structural analysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immuto Scientific Comparables
Compare Immuto Scientific with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| A-Alpha Bio | 83% | |
| Protai | 81% | |
| Talus Bio | 79% |
For institutional investors. Book with your work email.
Immuto Scientific Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed 2 | Sep 18, 2025 | ||||
| Grant | Aug 15, 2022 | ||||
| Seed | Oct 12, 2021 | ||||
| Grant | Mar 10, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Immuto Scientific Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Golden Angels Investors | Seed |
| Great Oaks Venture Capital | Seed 2, Seed |
| NIH RADx | Grant |
| Milwaukee Venture Partners | Seed |
| WARF Ventures | Seed 2 |
| Tundra Angels | Seed |
| DYDX Capital | Seed 2 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 447% MoM, from 51 to 279.
- Sep 18, 2025
Partnered with Daiichi Sankyo Co. Ltd. on drug discovery.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventNov 4, 2026
Immuto Scientific will present preclinical data on IMTO-4842.1, a mutation-agnostic ADC directed against an AML-specific surface protein conformer, at the ASH 2026 Annual Meeting.
- attends_eventNov 4, 2026
Immuto Scientific is slated to present research from its collaboration with the University of Wisconsin-Madison at ENA 2026, applying structural surfaceomics in patient-derived colorectal cancer models to identify new target opportunities.
For institutional investors. Book with your work email.
Immuto Scientific Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Immuto Scientific's valuation, stock price, and market status.
Is Immuto Scientific a public or private company?
Immuto Scientific is a private company.
What is the current stock price of Immuto Scientific?
Immuto Scientific is a private company, so its shares have no public market price. Caplight tracks Immuto Scientific's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Immuto Scientific worth (valuation)?
Valuation information for Immuto Scientific is not publicly available.
Can I buy Immuto Scientific stock?
Immuto Scientific shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Immuto Scientific's last funding round?
Immuto Scientific's most recent funding round was Seed 2 on September 18, 2025.
Who are the main investors in Immuto Scientific?
Key investors in Immuto Scientific include DYDX Capital, Wisconsin Investment Partners.
Will Immuto Scientific IPO soon?
No public IPO plans have been announced for Immuto Scientific.
How can I track Immuto Scientific secondary market activity?
Caplight tracks bids, offers, and trades in Immuto Scientific's shares on secondary markets.